1. Home
  2. ELTK vs PYPD Comparison

ELTK vs PYPD Comparison

Compare ELTK & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$9.45

Market Cap

76.9M

Sector

Technology

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$3.92

Market Cap

66.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
PYPD
Founded
1970
2008
Country
Israel
Israel
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.9M
66.2M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
ELTK
PYPD
Price
$9.45
$3.92
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
31.0K
86.0K
Earning Date
11-18-2025
11-12-2025
Dividend Yield
2.03%
N/A
EPS Growth
N/A
N/A
EPS
0.17
N/A
Revenue
$49,310,000.00
N/A
Revenue This Year
$18.60
N/A
Revenue Next Year
$9.04
N/A
P/E Ratio
$54.17
N/A
Revenue Growth
2.54
N/A
52 Week Low
$7.65
$2.30
52 Week High
$12.19
$4.07

Technical Indicators

Market Signals
Indicator
ELTK
PYPD
Relative Strength Index (RSI) 46.92 58.21
Support Level $9.17 $3.94
Resistance Level $9.80 $4.07
Average True Range (ATR) 0.46 0.14
MACD 0.14 0.01
Stochastic Oscillator 78.82 68.09

Price Performance

Historical Comparison
ELTK
PYPD

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: